Skip to main content

Preparation and In Vitro Characterization of Multifunctional Nanoemulsions for Simultaneous MR Imaging and Targeted Drug Delivery

Buy Article:

$105.00 plus tax (Refund Policy)

Cancer therapy can significantly benefit from simultaneous imaging and targeted drug delivery. Using oils rich in polyunsaturated fatty acids (PUFA), such as gamma-linolenic acid (GLA), we have formulated oil-in-water nanoemulsions for simultaneous magnetic resonance imaging (MRI) and site-specific drug delivery. The nanoemulsions, formulated with pine-nut oil that contains at least 20% GLA, consists of oil droplets stabilized with phosphatidylethanolamine conjugated to diethylenetriaminepentaacetic acid (DTPA) that provides high affinity for specific metal ions, and the lipophilic core, which can encapsulate hydrophobic anticancer drugs. In the present case, the nanoemulsions are loaded with paclitaxel, a potent anticancer drug and also with gadolinium ions (Gd3+) to provide contrast enhancement in magnetic resonance imaging (MRI). The Gd3+ loaded nanoemulsions have a diameter of around 100 nm and are small enough to pass easily through the vasculature. These nanoemulsions have been shown to reduce magnetic relaxation times in vitro and also to deliver drug efficiently in tumor cells, thus demonstrating the multifunctionality of the system.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: GADOLINIUM; IMAGE-GUIDED THERAPY; MRI CONTRAST AGENT; NANOEMULSIONS; PACLITAXEL

Document Type: Research Article

Publication date: 2006-10-01

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more